Three months therapy with ranitidine bismuth citrate (RBC) reduces H-pylori-associated gastritis and density of H-pylori but does not cure the infection.

被引：0
|
作者：
Graham, DY
Walsh, JH
Schubert, TT
Lanza, FL
Peura, DA
Peterson, W
Riff, DS
Yardley, J
Ciociola, AA
Kong, S
Wood, D
Webb, DD
机构：
[1] VET ADM MED CTR, HOUSTON, TX 77211 USA
[2] CURE, LOS ANGELES, CA USA
[3] DIGEST CONSULTANTS, TACOMA, WA USA
[4] INST CLIN RES, HOUSTON, TX USA
[5] UNIV VIRGINIA, CHARLOTTESVILLE, VA 22903 USA
[6] VET ADM MED CTR, DALLAS, TX 75216 USA
[7] GASTROENTEROL GRP, ANAHEIM, CA USA
[8] JOHNS HOPKINS MED CTR, BALTIMORE, MD USA
[9] GLAXO WELLCOME INC, RES TRIANGLE PK, NC USA
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A122 / A122
页数：1
相关论文
共 50 条
  • [31] IGG serology at 6 months is a reliable predictor for cure of H-pylori infection
    van de Wouw, BAM
    Laheij, RJF
    Schneeberger, PM
    de Boer, WA
    GASTROENTEROLOGY, 1999, 116 (04) : A357 - A357
  • [32] Triple therapy with ranitidine-bismuth citrate, clarithromycin and metronidazole to cure clarithromycin-resistant H. pylori
    Deprez, PH
    Burette, A
    De Prez, C
    Mana, F
    Avezani, V
    Glupczynski, Y
    GASTROENTEROLOGY, 2002, 122 (04) : A65 - A65
  • [33] Dual therapy with ranitidine bismuth citrate and clarithromycin is superior to omeprazole and amoxycillin in the cure of Helicobacter pylori infection
    Kolkman, JJ
    Tan, TG
    OudkerkPool, M
    vanKleef, WA
    Geraedts, AAM
    Meuwissen, SGM
    GASTROENTEROLOGY, 1997, 112 (04) : A180 - A180
  • [34] Effect of H-pylori infection on H+/K+-ATPase mRNA expression in gastric fundic gland mucosa in patients with chronic active gastritis and H-pylori infection.
    Furuta, T
    Baba, S
    Takashima, M
    Hanai, H
    Taneko, E
    GASTROENTEROLOGY, 1998, 114 (04) : A128 - A128
  • [35] Does Helicobacter pylori serology predict the intragastric bacterial density of H-pylori and the histological severity of gastritis?
    Xia, HHX
    Kalantar, J
    Wyatt, JM
    Adams, S
    Cheung, K
    Mitchell, HM
    Talley, NJ
    GASTROENTEROLOGY, 1998, 114 (04) : A336 - A336
  • [36] Ranitidine bismuth citrate (RBC) and azithromycin (Az) based therapy for Helicobacter pylori infection in peptic ulcer patients
    Duvnjak, M
    Vucelic, B
    Katicic, M
    Krizman, I
    Culig, J
    Pavic-Sladoljev, D
    Naletilic, D
    GUT, 1999, 45 : A118 - A118
  • [37] Double therapy with ranitidine bismuth citrate (RBC) and clarithromycin during two weeks, has lower efficacy than triple therapy with RBC, clarithromycin and amoxicillin during one week in the eradication of H. pylori infection.
    Hergueta, P
    Rojas, M
    Romero, R
    Gomez, BJ
    Pellicer, FJ
    Herrerias, JM
    GASTROENTEROLOGY, 2000, 118 (04) : A1245 - A1245
  • [38] Dual or triple therapy combining omeprazole with amoxicillin and/or clarithromycin for H-pylori infection.
    Burette, A
    Lamy, V
    Ligny, G
    Cabooter, M
    Ramdani, B
    Ectors, N
    Glupczynski, Y
    GASTROENTEROLOGY, 1997, 112 (04) : A80 - A80
  • [39] Rescue therapy after H-pylori treatment failure:: Omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole
    Gisbert, JP
    Marcos, S
    Gisbert, JL
    Carpio, D
    Valle, J
    Cabrera, MM
    Cruzado, AI
    Garcia-Gravalos, R
    Pajares, JM
    GASTROENTEROLOGY, 1999, 116 (04) : A172 - A172
  • [40] Ranitidine bismuth citrate (RBC) plus amoxycillin and tinidazole as second-line therapy for H.pylori infection after failure of the standard "Maastricht triple therapy"
    Perri, F
    Villani, MR
    Annese, V
    Quitadamo, M
    Niro, GA
    Mangia, A
    Andriulli, A
    GASTROENTEROLOGY, 2001, 120 (05) : A581 - A581
12345